Mechanisms of Protein Homeostasis in Aging and Diseases

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 179

Special Issue Editors


E-Mail Website
Guest Editor
NOVA Medical School - Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal
Interests: proteostasis; age-related macular degeneration; retina; extracellular vesicles

E-Mail Website
Guest Editor
NOVA Medical School - Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal
Interests: proteostasis; intracellular trafficking; intercellular communication; exosomes; LAMP2A

Special Issue Information

Dear Colleagues,

It is widely accepted that the accumulation of toxic proteins trails a progressive decline in the mechanisms that regulate protein homeostasis, or proteostasis, during aging. However, despite significant efforts, progress in terms of novel or improved therapies to either boost proteostasis networks or promote the removal of proteotoxic oligomers/aggregates, as well as prevent or even significantly delay age-related pathologies, has been rather limited.

Therefore, we have reached the point where we need to revisit the knowledge produced during past decades, go back to the drawing board, and use innovative in vitro as well as in vivo approaches to study proteostasis.

We know that proteostasis involves a network of cellular mechanisms, including protein synthesis, folding, transport, and degradation, as well as a transcellular network involving intercellular and intertissue communication in response to stress.

In this Special Issue we want to focus on cell-autonomous versus cell-nonautonomous proteostasis mechanisms, intercellular signaling in the regulation of proteostasis, cooperation between mitotic and postmitotic cells in proteostasis maintenance, the use of organoids and other innovative models for the study of proteostasis, new bioengineering tools, including the use of stem cells and their secretome for the development of new therapies, and new drug screenings in addition to improved tools for early diagnostics in age-related diseases.

Dr. Paulo Pereira
Dr. João Vasco Ferreira
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aging
  • proteostasis
  • age-related diseases

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop